{
    "Trade/Device Name(s)": [
        "Aptima CMV Quant Assay"
    ],
    "Submitter Information": "Hologic, Inc.",
    "510(k) Number": "K243935",
    "Predicate Device Reference 510(k) Number(s)": [
        "P210029"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PAB"
    ],
    "Summary Letter Date": "December 19, 2024",
    "Summary Letter Received Date": "December 20, 2024",
    "Submission Date": "December 17, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3180"
    ],
    "Regulation Name(s)": [
        "Quantitative Cytomegalovirus Nucleic Acid Tests For Transplant Patient Management"
    ],
    "Analyte Class(es)": [
        "virology",
        "transplant"
    ],
    "Analyte(s)": [
        "Cytomegalovirus (CMV) DNA"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Panther system",
        "Panther Fusion system"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid amplification",
        "Real-time Transcription Mediated Amplification (TMA)"
    ],
    "Methodologies": [
        "Molecular amplification",
        "Real-time detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Calibrator",
        "Control",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Aptima CMV Quant Assay using real-time TMA on the Panther system for quantitation of CMV DNA in plasma from transplant patients with an updated protocol for proteinase K treatment.",
    "Indications for Use Summary": "Quantitation of human cytomegalovirus (CMV) DNA in EDTA plasma on the fully automated Panther system to aid in management of solid-organ and hematopoietic stem cell transplant patients; not intended for CMV screening in blood or blood products.",
    "fda_folder": "Microbiology"
}